{"paper_id":"6f4a6f10-815e-4f7b-a832-0ded3c3f298f","body_text":"References\nWatanabe A, Taniguchi F, Izawa M, Suou K et al (2009) The role of survivin in the resistance of endometriotic stromal cells to drug-induced apoptosis. Hum Reprod 24(12):3172–3179\nHapangama DK, Turner MA, Drury JA, Quenby S, Saretzki G, Martin-Ruiz C et al (2008) Endometriosis is associated with aberrant endometrial expression of telomerase and increased telomere length. Hum Reprod 23:1511–1519\nMaida Y, Kyo S, Kanaya T, Wang Z, Yatabe N, Tanaka M et al (2002) Direct activation of telomerase by EGF through Ets-mediated transactivation of TERT via MAP kinase signaling pathway. Oncogene 21:4071–4079\nZhihong AI, Yin L, Zhou X, Zhu Y et al (2006) Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer. Cancer 107:746–756\nZhou WD, Chen QH, Chen QX (2010) The action of p38MAP Kinase and its inhibitors on endometriosis. Yao Xue Xue Bao 45:548–554\nYoshino O, Osuga Y, Hirota Y, Koga K et al (2004) Possible pathophysiological roles of miogeno-activated protein kinases (MAPKs) in endometriosis. Am J Reprod Immunol 52:306–311\nYotova IY, Quan P, Leditzing N, Beer U et al (2011) Abnormal activation of Ras/Raf/MAPK and RhoA/ROCKII signaling pathways in eutopic endometrial stromal cells of patients with endometriosis. Hum Reprod 26:885–897\nJi Ru-Rong (2009) Gereau RW, Malcangio M, Strichartz GR. MAP kinase and pain. Brain Res Rev 60:135–148\nConflict of interest\nThe authors declare there is no conflict of interest.\nAuthor information\nAuthors and Affiliations\nCorresponding author\nRights and permissions\nAbout this article\nCite this article\nMormile, R., Vittori, G. MAPK signaling pathway and endometriosis: what is the link?. Arch Gynecol Obstet 287, 837–838 (2013). https://doi.org/10.1007/s00404-012-2587-9\nReceived:\nAccepted:\nPublished:\nIssue date:\nDOI: https://doi.org/10.1007/s00404-012-2587-9","source_license":"public-domain-us","license_restricted":false}